Genetic Susceptibility to Clinically Aggressive Prostate Cancer Project Leader: Janet Stanford, Ph.D. Co-leader: Daniel Lin, M.D. Of the estimated 168,811 men who will be treated for prostate cancer (PC) with curative intent in 2006, >30% will ultimately experience disease recurrence, metastasis, and die of PC. There is substantial uncertainty, however,
Qian DZ, Huang CY, O'Brien CA, Coleman IM, Garzotto M, True LD, Higano CS, Vessella R, Lange PH, Nelson PS, Beer TM. Prostate cancer-associated gene expression alterations determined from needle biopsies. Clin Cancer Res. 2009 May 1;15(9):3135-42. Epub 2009 Apr 14. PubMed PMID: 19366833. PURPOSE: To accurately identify gene
